Karl Pechmann is a Chartered Accountant and Chartered Secretary with over 15 years of experience.
Prior to becoming chief financial officer and company secretary of OncoSil in March 2020, Mr Pechmann was the chief financial officer and company secretary of ASX-listed regulatory technology company Kyckr for almost 4 years. He was also the finance director of ASX-listed biotech company Immutep and held senior finance roles at ASX-listed and multinational organisations.